PubMed Health treatment related to Antiphospholipid Syndrome: 63
Antiphospholipid antibody syndrome (APS) has no cure. However, medicines can help prevent complications. The goals of treatment are to prevent blood clots from forming and keep existing clots from getting larger. You may have APS and another autoimmune disorder , such as lupus . If so, it's important to control that condition as well. When the other condition is controlled, APS may cause fewer problems. Research is ongoing for new ways to treat APS.
Drugs for Antiphospholipid Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 77)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Warfarin |
Approved |
Phase 4 |
|
81-81-2, 129-06-6 |
54678486 |
Synonyms:
(Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarin
(Phenyl-1 acetyl-2 ethyl) 3-hydroxy-4 coumarine
(S)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2-benzopyrone
1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone
200 Coumarin
3-(1'-Phenyl-2'-acetylethyl)-4-hydroxycoumarin
3-(Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
3-(alpha-Phenyl-beta-acetylaethyl)-4-hydroxycumarin
3-(alpha-Phenyl-beta-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3- (3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3- (3-oxo-1-phenyl-butyl)-cumarin
4-Hydroxy-3-(3-oxo-1-fenyl-butyl) cumarine
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one
4-Hydroxy-3-(3-oxo-1-phenylbutyl)coumarin
4-Hydroxy-3-(3-oxo-1-phenyl-butyl)-cumarin
4-Idrossi-3- (3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-)-fenil-butil)-cumarine
4-Idrossi-3-(3-oxo-1-fenil-butil)-cumarine
4oh-Coumarin deriv.
aldo Brand OF warfarin sodium
Aldocumar
Antigen brand OF warfarin sodium
Apotex brand OF warfarin sodium
apo-Warfarin
Arab rat death
Arab rat deth
Athrombin
Athrombine-K
Athrombin-K
Bailly brand OF warfarin sodium
Boots brand OF warfarin sodium
Bristol-myers squibb brand OF warfarin sodium
Brumolin
Choice
Compound 42
CO-Rax
Coumadin
Coumadin Tabs
Coumadin®|Marevan®|panwarfin
Coumadine
Coumafen
Coumafene
Coumaphen
Coumaphene
Coumarins
Coumefene
Cov-R-tox
D-CON
delta-CON
Dethmor
Dethnel
Dicusat e
DL-3-(alpha-Acetonylbenzyl)-4-hydroxycoumarin
Eastern states duocide
Estedi brand OF warfarin sodium
fasco Fascrat powder
Frass-ratron
Genpharm brand OF warfarin sodium
Gen-warfarin
Goldshield brand OF warfarin sodium
Jantoven
Killgerm sewarin P
Kumader
Kumadu
Kumatox
Kypfarin
Latka 42
Liqua-tox
Maag rattentod cum
Marevan
|
Mar-frin
Martin'S mar-frin
Maveran
Mouse pak
NSC-59813
PANWARFIN
Place-pax
Potassium, warfarin
Prothromadin
Rat & mice bait
Rat and mice bait
Rat-alpha-way
Rat-a-way
Rat-beta-gon
Rat-b-gon
Rat-gard
Rat-kill
Rat-mix
Rat-O-cide #2
Rat-O-cide no. 2
Rat-ola
Ratorex
Ratox
Ratoxin
Ratron
Ratron g
Rats-NO-more
Ratten-koederrohr
Rattenstreupulver neu schacht
Rattenstreupulver new schacht
Rattentraenke
Rat-trol
Rattunal
RAX
RCR Grey squirrel killer concentrate
Rodafarin
Rodafarin c
ro-Deth
Rodex
Rodex blox
Rosex
Rough & ready mouse mix
Rough and ready mouse mix
Sakarat
Sewarin
Sodium, warfarin
Sofarin
Solfarin
Sorexa plus
Spray-trol brand roden-trol
Tedicumar
Temus W
Tintorane
Tox-hid
Twin light rat away
Vampirinip II
Vampirinip III
Waran
Warf 42
Warfant
Warfarat
WARFARIN
Warfarin Plus
Warfarin potassium
Warfarin Q
Warfarin sodium
Warfarina
Warfarine
Warficide
Warfilone
Zoocoumarin
|
|
2 |
|
Acetaminophen |
Approved |
Phase 4 |
|
103-90-2 |
1983 |
Synonyms:
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4'-Hydroxyacetanilide
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
A.F. anacin
ABDINE
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-tap
Acenol
Acephen
Acertol
Aceta elixir
Aceta tablets
Acetaco
Acetagesic
Acetalgin
Acetamidophenol
Acetaminofen
ACETAMINOFÉN
ACETAMINOPHEN
Acetaminophen uniserts
acetaminophen|Panadol®|Tylenol®
Acetaminophene
ACÉTAMINOPHÈNE
Acetamol
Acetofen
Acetominophen
Actamin
Actamin extra
Actamin super
Actifed plus
Actimol
Actimol chewable tablets
Actimol children's suspension
Actimol infants' suspension
Actimol junior strength caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
alpha-Per
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen max
Anacin
Anacin 3
Anacin3
Anacin-3
Anacin-3 extra strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
ANGIERS
Anhiba
Anoquan
Anti-algos
Antidol
Apacet
Apacet capsules
Apacet elixir
Apacet extra strength caplets
Apacet extra strength tablets
Apacet regular strength tablets
Apadon
Apamid
Apamide
APAP
a-Per
Apitrelal
Apo-acetaminophen
Arfen
Asetam
Asomal
Aspac
Aspirin free anacin maximum strength caplets
Aspirin free anacin maximum strength gel caplets
Aspirin free anacin maximum strength tablets
Aspirin-free anacin
Aspirin-free excedrin caplets
Asplin
Atasol
Atasol caplets
Atasol drops
Atasol forte caplets
Atasol forte tablets
Atasol oral solution
Atasol tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap HC
Banesin
Bayer Select
Bayer select allergy-sinus
Bayer select head cold
Bayer select headache pain
Bayer select maximum strength headache pain relief formula
Bayer select menstrual multi-symptom
Bayer select sinus pain relief
Benmyo
Ben-u-ron
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
Cadafen
Calapol
Calmanticold
Calpol
CALPOL SIX PLUS
CALPOL SIX PLUS FASTMELTS
Capital with codeine
Captin
Causalon
Cefalex
Cetadol
CHILD LEMSIP
Children'S acetaminophen elixir drops
Children'S acetaminophen oral solution
Children'S tylenol chewable
Claradol codeine
Clixodyne
Codabrol
COD-Acamol forte
Codalgin
Codapane
Codicet
Codisal
Codisal forte
Codoliprane
Codral pain relief
Cofamol
CO-Gesic
Conacetol
Contac cough & sore throat formula
Contra-schmerz p
Coricidin
Coricidin D
Coricidin sinus
Cosutone
Croix blanche
CUPANOL
Cuponol
Curadon
Curpol
Custodial
DAFALGAN
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril extra-strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
DHC Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
DISPROL INFANT
DISPROL JNR
DISPROL PAED
Dolcor
Dolefin
Dolegrippin
Dolene ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol forte
Dolorstop
Dolotec
Dolprone
Dol-stop
Dorocoff
Dresan
Dristan cold no drowsiness
Dristancito
Drixoral Plus
Dularin
Duracetamol
Duradyne DHC
Durapan
Dymadon
Dymadon co
Dymadon forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-plus
Eu-med
Excedrin
Excedrin caplets
Excedrin extra strength caplets
Excipain
Exdol
Exdol strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-gesic
Febrolin
Femcet
Fendon
FENNINGS
Fensum
Fepanil
Feverall
Feverall junior strength
Feverall sprinkle caps junior strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon p
Freka-cetamol
GALPAMOL
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap children's elixir
Genapap children's tablets
Genapap extra strength caplets
Genapap extra strength tablets
Genapap regular strength tablets
Genebs
Genebs extra strength caplets
Genebs regular strength tablets
Genebs X-tra
Geralgine-p
Gripin bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hycomine compound
Hydrocet
Hydroxyacetanilide
Hy-phen
Ildamol
Inalgex
Infadrops
Infants' feverall
Influbene N
Injectapap
Intensin
Janupap
Junior disprol
JUNIOR PARAPAED
Kataprin
Kinder finimal
Korum
Kratofin simplex
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liquagesic
Liquigesic co
Liquiprin
Liquiprin children's elixir
Liquiprin infants" drops
Lonarid
Lonarid mono
Lorcet-HD
Lortab
Lupocet
Lyteca
Lyteca syrup
Magnidol
Malex N
Malgis
Malidens
MANDANOL
Maxadol
Medigesic plus
MEDINOL
MEDINOL FOR CHILDREN
MEDINOL OVER 6
Medinol paediatric
MEDINOL UNDER 6
MEDISED PLAIN
Medocodene
Melabon infantil
Mexalen
Midol maximum strength
Midol PM night time formula
Midol regular strength
Midol teen formula
Migraleve yellow
Minafen
Minoset
MIRADOL
Miralgin
Momentum
|
mono Praecimed
Multin
N-(4-Hydroxyphenyl)acetamide
N-(4-Hydroxyphenyl)acetanilide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
Naldegesic
NAPA
Napafen
Napap
Naprinol
Nealgyl
Nebs
NeoCitran
Neodol
Neodolito
Neo-fepramol
Neopap
Neotrend
Neuridon
New cortal for children
NilnOcen
Nina
Nobedon
Nodolex
NO-Febril
Noral
Norcet
Norco
NSC-109028
NSC-3991
O-Acetaminophenol
OFIRMEV
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/apap 500
Oxycodone 5/apap 500
p-(Acetylamino)phenol
Paceco
Pacemo
Pacemol
Pacet
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine co
Panadiene
PANADO
Panado-co
Panado-co caplets
Panadol
PANADOL ACTIFAST
PANADOL ACTIFAST SOLB
PANADOL ADVAN
Panadol extra strength
PANADOL JNR
Panadol junior strength caplets
Panadol maximum strength caplets
Panadol maximum strength tablets
PANADOL OA
Panaleve
PANALEVE 6 PLUS
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-deine #3
Papa-deine #4
Paracemol
Paracenol
Paracet
Paracetamol
PARACÉTAMOL
Paracetamol al
Paracetamol antipanin p
Paracetamol basics
Paracetamol BC
Paracetamol DC
Paracetamol dr. schmidgall
Paracetamol fecofar
Paracetamol genericon
Paracetamol hanseler
Paracetamol harkley
Paracetamol heumann
Paracetamol hexal
Paracetamol italfarmaco
Paracetamol nycomed
Paracetamol PB
Paracetamol raffo
Paracetamol ratiopharm
Paracetamol rosch
Paracetamol saar
Paracetamol smithkline beecham
Paracetamol stada
Paracetamol von CT
Paracetamol winthrop
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
PARAMIN
Paramol
Paramolan
Paranox
PARAPAED JNR
PARAPAED SIX PLUS
Parapan
Parasedol
Parasin
Paraspen
Para-suppo
Para-tabs
PARAVICT
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
PCM Paracetamol lichtenstein
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-demi
Percogesic with codeine
Perdolan mono
PERFALGAN
Pe-tam
Phenaphen
Phenaphen caplets
Phenaphen w/codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin forte
P-HYDROXY-ACETANILID
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
Pinex
Piramin
Pirinasol
PLACIDEX
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet world
Redutemp
Reliv
Remedol
Rhinex D-lay tablets
RIMADOL
Rivalgyl
Robigesic
Robitussin night relief
Rockamol plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sinedol
Sine-OFF sinus medicine caplets
Sinmol
Sinubid
SK-Apap
Snaplets-FR
Spalt fur die nacht
Spalt N
ST Joseph aspirin-free
ST Joseph aspirin-free for children
St. joseph cold tablets for children
St. joseph fever reducer
Stanback
Stopain
Sudafed severe cold formula
Sudafed sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-m
Synalgos-DC-a
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol extra strength caplets
Tapanol extra strength tablets
Tapar
Tavist allergy/sinus/headache
Tazamol
Temlo
Tempanal
Tempra
Tempra caplets
Tempra chewable tablets
Tempra d.s
Tempra drops
Tempra syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
TIXYMOL
Tizide
Tocris-1706
Toximer p
Tralgon
TRAMIL 500
Treupel mon
Treupel N
Treuphadol
Triad
Triaminic sore throat formula
Triaprin
Tricoton
Tussapap
Tycolet
TYL
Tylenol
Tylenol allergy sinus
Tylenol arthritis extended relief
Tylenol caplets
Tylenol children's chewable tablets
Tylenol children's elixir
Tylenol children's suspension liquid
Tylenol drops
Tylenol elixir
Tylenol extra strength adult liquid pain reliever
Tylenol extra strength caplets
Tylenol extra strength gelcaps
Tylenol extra strength tablets
Tylenol gelcaps
Tylenol infants drops
Tylenol infants" suspension drops
Tylenol junior strength caplets
Tylenol junior strength chewable tablets
Tylenol regular strength caplets
Tylenol regular strength tablets
Tylenol tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor richet
Vicodin
Vicodin es
Vicodin HP
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
|
|
3 |
|
Apixaban |
Approved |
Phase 4 |
|
503612-47-3 |
10182969 |
Synonyms:
APIXABAN
APIXABÁN
Apixabanum
BMS 562247-01
|
BMS-562247
BMS-562247|Eliquis®
BMS-562247-01
Eliquis
|
|
4 |
|
Vaccines |
|
Phase 4 |
|
|
|
5 |
|
Acenocoumarol |
Approved, Investigational |
Phase 3 |
|
152-72-7 |
54676537 9052 |
Synonyms:
3-(a-(4'-Nitrophenyl)-b-acetylethyl)-4-hydroxycoumarin
3-(a-(p-Nitrophenol)-b-acetylethyl)-4-hydroxycoumarin
3-(a-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin
3-(a-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin
3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin
3-(alpha-(p-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin
3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin
3-(alpha-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin
3-(alpha-p-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin
3-(a-p-Nitrophenyl-b-acetylethyl)-4-hydroxycoumarin
3-(Α-(4'-nitrophenyl)-β-acetylethyl)-4-hydroxycoumarin
3-(Α-(p-nitrophenol)-β-acetylethyl)-4-hydroxycoumarin
3-(Α-acetonyl-4-nitrobenzyl)-4-hydroxycoumarin
3-(Α-acetonyl-p-nitrobenzyl)-4-hydroxycoumarin
3-(Α-p-nitrophenyl-β-acetylethyl)-4-hydroxycoumarin
4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one
4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one
Acenocoumarin
ACENOCOUMAROL
ACÉNOCOUMAROL
Acenocoumarol alliance brand
Acenocoumarol ciba-geigy brand
Acenocoumarol novartis brand
Acenocoumarolum
Acenocoumarolum [inn-latin]
Acenocumarol
Acenocumarolo
|
Acenokumarin
Alliance brand OF acenocoumarol
Ascumar
Ciba geigy brand OF acenocoumarol
Ciba-geigy brand OF acenocoumarol
Mini sintrom
Mini-sintrom
MiniSintrom
Neositron
Nicoumalone
Nicumalon
Nitrophenylacetylethyl-4-hydroxycoumarine
Nitrovarfarian
Nitrowarfarin
Novartis brand OF acenocoumarol
SIN350
Sincoumar
Sinkumar
Sinthrom
Sinthrome
Sinthrome®|Sintrom®
Sintrom
Syncoumar
Syncumar
Synthrom
Syntrom
Zotil
|
|
6 |
|
Benzocaine |
Approved, Investigational |
Phase 2, Phase 3 |
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
7 |
|
Tannic acid |
Approved |
Phase 2, Phase 3 |
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
8 |
|
Belimumab |
Approved |
Phase 2, Phase 3 |
|
356547-88-1 |
|
Synonyms:
BEL114333
BEL-114333
BELIMUMAB
BELIMUMAB (GENETICAL RECOMBINATION)
BENLYSTA
GSK1550188
|
GSK-1550188
HGS1006
HGS-1006
LYMPHOSTAT-B
LYMPHOSTAT-B BENLYSTA
|
|
9 |
|
Rivaroxaban |
Approved |
Phase 3 |
|
366789-02-8 |
9875401 |
Synonyms:
BAY 59-7939
BAY 59-7939|Xarelto®
BAY59-7939
BAY-59-7939
|
JNJ39039039
JNJ-39039039
RIVAROXABAN
XARELTO
|
|
10 |
|
Hydroxychloroquine |
Approved |
Phase 3 |
|
118-42-3 |
3652 |
Synonyms:
(+-)-Hydroxychloroquine
(±)-HYDROXYCHLOROQUINE
2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol
2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol
7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-(4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino)quinoline
7-Chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-b-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[4-(N-ethyl-N-β-hydroxyethylamino)-1-methylbutylamino]quinoline
7-Chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline
Axemal
DOLQUINE
Dolquine®|Plaquenil®
Ercoquin
Gen-Hydroxychloroquine 200mg Tablets
HCQ
Hidroxicloroquina
|
Hidroxicloroquina [inn-spanish]
Hydroxychlorochin
Hydroxychloroguine
HYDROXYCHLOROQUINE
Hydroxychloroquine sulfate
Hydroxychloroquine sulfate (1:1) salt
Hydroxychloroquinum
Hydroxychloroquinum [inn-latin]
Idrossiclorochina [dcit]
NSC4375
Oxichlorochine
Oxichlorochinum
Oxichloroquine
Oxychlorochin
Oxychloroquine
Plaquenil
Polirreumin
Quensyl
|
|
11 |
|
Antivitamins K |
|
Phase 3 |
|
|
|
12 |
|
Immunologic Factors |
|
Phase 2, Phase 3 |
|
|
|
13 |
|
Immunosuppressive Agents |
|
Phase 2, Phase 3 |
|
|
|
14 |
|
Factor Xa Inhibitors |
|
Phase 3 |
|
|
|
15 |
|
HIV Protease Inhibitors |
|
Phase 3 |
|
|
|
16 |
|
Serine Proteinase Inhibitors |
|
Phase 3 |
|
|
|
17 |
|
Antithrombins |
|
Phase 3 |
|
|
|
18 |
|
Antithrombin III |
|
Phase 3 |
|
|
|
19 |
|
protease inhibitors |
|
Phase 3 |
|
|
|
Synonyms:
|
20 |
|
Antirheumatic Agents |
|
Phase 3 |
|
|
|
21 |
|
Anti-Infective Agents |
|
Phase 3 |
|
|
|
22 |
|
Antiprotozoal Agents |
|
Phase 3 |
|
|
|
23 |
|
Antiparasitic Agents |
|
Phase 3 |
|
|
|
24 |
|
Antimalarials |
|
Phase 3 |
|
|
|
25 |
|
Autoantibodies |
|
Phase 3 |
|
|
|
26 |
|
Serine |
Investigational, Nutraceutical |
Phase 3 |
|
56-45-1 |
5951 |
Synonyms:
(-)-Serine
(2S)-2-Amino-3-hydroxypropanoate
(2S)-2-Amino-3-hydroxypropanoic acid
(3R,3'r,6S)-4,5-DIDEHYDRO-5,6-dihydro-b,b-carotene-3,3'-diol
(3R,3'r,6S)-4,5-DIDEHYDRO-5,6-dihydro-BETA,BETA-carotene-3,3'-diol
(3R,3'r,6S)-4,5-DIDEHYDRO-5,6-dihydro-β,β-carotene-3,3'-diol
(S)-(-)-Serine
(S)-2-Amino-3-hydroxypropanoate
(S)-2-Amino-3-hydroxy-propanoate
(S)-2-Amino-3-hydroxypropanoic acid
(S)-2-Amino-3-hydroxy-propanoic acid
(S)-a-Amino-b-hydroxypropionate
(S)-a-Amino-b-hydroxypropionic acid
(S)-alpha-Amino-beta-hydroxypropionate
(S)-alpha-Amino-beta-hydroxypropionic acid
(S)-b-Amino-3-hydroxypropionate
(S)-b-Amino-3-hydroxypropionic acid
(S)-beta-Amino-3-hydroxypropionate
(S)-beta-Amino-3-hydroxypropionic acid
(S)-Serine
(S)-Α-amino-β-hydroxypropionate
(S)-Α-amino-β-hydroxypropionic acid
2-Amino-3-hydroxypropanoate
2-Amino-3-hydroxypropanoic acid
3-Hydroxy-L-alanine
|
alpha-Amino-beta-hydroxypropionic acid
beta-Hydroxyalanine
beta-Hydroxy-L-alanine
b-Hydroxyalanine
b-Hydroxy-L-alanine
Bo-xan
e 161b
L Serine
L-(-)-Serine
L-2-Amino-3-hydroxypropionate
L-2-Amino-3-hydroxypropionic acid
L-3-Hydroxy-2-aminopropionate
L-3-Hydroxy-2-aminopropionic acid
L-3-Hydroxy-alanine
L-Ser
L-Serin
L-Serine
S
Ser
Serina
SERINE
Serinum
Xanthophyll
Β-hydroxyalanine
Β-hydroxy-L-alanine
|
|
27 |
|
Rituximab |
Approved |
Phase 2 |
|
174722-31-7 |
|
Synonyms:
ABP-798
ANTICD20
CT-P10
HS006
HS-006
HS-006 (RITUXIMAB BIOSIMILAR)
HSDB 7455|IDEC-C2B8|MabThera®|Rituxan®
IDEC-102
IDEC-C2B8
IG GAMMA-1 CHAIN C REGION
Ig gamma-2A chain C region, membrane-bound form
MABTHERA
MABTHERA RITUXAN
|
R-105 IDEC-102
radiolabeled murine anti-CD20
RG-105
RHCACD20MA
RITUXAN
RITUXIMAB
rituximab-abbs
rituximab-arrx
rituximab-pvvr
SAIT101
SAIT-101
Zevalin
|
|
28 |
|
Eculizumab |
Approved, Investigational |
Phase 2 |
|
219685-50-4 |
|
Synonyms:
5G1.1
ABP-959
ECULIZUMAB
H5G1.1
|
H5G1.1VHC+H5G1.1VLC
H5G11
H5G1-1
SOLIRIS
|
|
29 |
|
Zanubrutinib |
Approved, Investigational |
Phase 2 |
|
1691249-45-2 |
135565884 |
Synonyms:
(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide
7-(1-Acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide
BGB-3111
|
BGB-3111|BGB3111|Brukinsa®|compound 27b [US9447106]
Brukinsa
ZANUBRUTINIB
|
|
30 |
|
Certolizumab pegol |
Approved |
Phase 2 |
|
428863-50-7 |
|
Synonyms:
|
CERTOLIZUMAB PEGOL
CIMZIA
PHA-738144
|
|
31 |
|
Antineoplastic Agents, Immunological |
|
Phase 2 |
|
|
|
32 |
|
Hormones |
|
Phase 2 |
|
|
|
33 |
|
Calcium, Dietary |
|
Phase 2 |
|
|
|
34 |
|
Complement System Proteins |
|
Phase 2 |
|
|
|
35 |
|
Protein Kinase Inhibitors |
|
Phase 2 |
|
|
|
36 |
|
Calcium |
Nutraceutical |
Phase 2 |
|
7440-70-2 |
271 |
Synonyms:
Ca
Ca(2+)
Ca2+
Calcio
CALCIUM
Calcium element
|
CALCIUM ion
Calcium(2+)
Calcium, doubly charged positive ion
Calcium, elemental
Elemental calcium
Kalzium
|
|
37 |
|
Lenograstim |
Approved, Investigational |
|
|
135968-09-1 |
|
Synonyms:
G-CSF (CHO cell derived)
Glycosylated recombinant G-CSF
Glycosylated recombinant granulocyte colony stimulating factor
GRANOCYTE-13
GRANOCYTE-34
Granulocyte colony stimulating factor 3 (CHO cell derived)
|
Granulocyte colony-stimulating factor lenograstim
Lenograstim
Lenograstim (genetical recombination)
Lenograstim rDNA
RG-CSF
|
|
38 |
|
Rofecoxib |
Approved, Investigational, Withdrawn |
|
|
162011-90-7 |
5090 |
Synonyms:
3-PHENYL-4-[4-(METHYLSULFONYL)PHENYL]-2(5H)-FURANONE
4-[4-(METHYLSULFONYL)PHENYL]-3-PHENYL-2(5H)-FURANONE
4-[4-(METHYLSULFONYL)PHENYL]-3-PHENYLFURAN-2(5H)-ONE
CEOXX
Ceoxx®|MK 966|Vioxx®
M01AH02
MK 966
MK 996
|
MK0966
MK-0966
MK-966
ROFECOXIB
Rofécoxib
Rofecoxibum
VIOXX
|
|
39 |
|
Celecoxib |
Approved, Investigational |
|
|
169590-42-5 |
2662 |
Synonyms:
4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide
4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENE-1-SULFONAMIDE
4-[5-(4-METHYLPHENYL)-3-TRIFLUOROMETHYL)-1H-PYRAZOL-YL]BENZENESULFONAMIDE
CELEBRA
Celebrex
CELECOX
Celecox®|Elyxyb® (DFN-15; oral solution)|Onsenal®|SC-58635|SC58635
Celecoxib
Célécoxib
|
Celecoxibum
Celocoxib
DFN15
DFN-15
Onsenal
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide
p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulphonamide
SC-58635
|
|
40 |
|
Phylloquinone |
Approved, Investigational |
|
|
84-80-0 |
5284607 |
Synonyms:
(2S)-2-(Henicosanoyloxy)-3-(tridecanoyloxy)propyl (7Z,10Z,19Z)-docosa-4,7,10,13,16,19-hexaenoic acid
2',3'-trans-Vitamin K1
2’,3’-trans-vitamin K1
2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione
2-Methyl-3-[(2E)-3,7,11,15-tetramethyl-2-hexadecenyl]naphthoquinone
2-METHYL-3-[(2E)-3,7,11,15-TETRAMETHYLHEXADEC-2-EN-1-YL]-1,4-DIHYDRONAPHTHALENE-1,4-DIONE
2-METHYL-3-[(2E,7R,11R)-3,7,11,15-TETRAMETHYLHEXADEC-2-EN-1-YL]NAPHTHALENE-1,4-DIONE
2-methyl-3-[(E,7R,11R)-3,7,11,15-tetramethylhexadec-2-enyl]naphthalene-1,4-dione
2-METHYL-3-PHYTHYL-1,4-NAPHTHOCHINON
2-Methyl-3-phytyl-1,4-naphthochinon
2-Methyl-3-phytyl-1,4-naphthoquinone
2-METHYL-3-PHYTYL-1,4-NAPTHOQUINONE
3-Phytylmenadione
alpha-Phylloquinone
ANTIHEMORRHAGIC VITAMIN
a-Phylloquinone
AQUA MEPHYTON
AQUA-MEPHYTIN
Aquamephyton
COMBINAL K1
Fitomenadiona
FITOMENADIONE
KANAVIT
KATIV N
KEPHTON
KINADION
K-JECT
|
Konakion
KONAKION MM
KONAKION MM PAED
MEPHYTON
MONODION
MONO-KAY
NEOKAY
NSC-270681
ORAKAY
Phyllochinon
Phyllochinonum
Phyllohydroquinone
Phylloquinone
PHYLLOQUINONE E-FORM
PHYTHYL-MENADION
Phytomenadione
Phytomenadionum
Phytonadione
Phytonadionum
Phytylmenadione
SYNTHEX P
trans-Phylloquinone
VITAMIN K
Vitamin K 1
Vitamin K hydroquinone (phylloquinone)
Vitamin K1
Α-phylloquinone
|
|
41 |
|
Sodium citrate |
Approved, Investigational |
|
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
42 |
|
Edoxaban |
Approved |
|
|
480449-70-5 |
11635624 10280735 |
Synonyms:
DU-176
DU-176|DU-176b|edoxaban tosylate|Lixiana®|Savaysa®
DU-176B
EDOXABAN
|
EDOXABAN TOSYLATE
LIXIANA
SAVAYSA
|
|
43 |
|
Dabigatran |
Approved, Investigational |
|
|
211914-51-1 |
216210 |
Synonyms:
BIBR 1048
BIBR-953
BIBR-953-ZW
DABIGATRAN
Dabigatran etexilate
Dabigatran etexilate mesylate
|
Etexilate mesylate, dabigatran
Etexilate, dabigatran
Mesylate, dabigatran etexilate
N-((2-(((4-(Aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine
Pradaxa
|
|
44 |
|
Plasminogen |
Approved |
|
|
9001-91-6 |
|
Synonyms:
1-glutamylplasminogen
Human plasminogen
Plasma trypsinogen
|
plasminogen, human-tvmh
Profibrinolysin
|
|
45 |
|
Thrombin |
Approved, Investigational |
|
|
|
|
Synonyms:
coagulation factor II
THROMBIN
Thrombin bovine
|
Thrombin, Topical (Bovine)
THROMBOSTAT
|
|
46 |
|
Protein C |
Approved |
|
|
|
|
Synonyms:
autoprothrombin IIA
blood coagulation factor XIV
Human protein C
Protein C (coagulation inhibitor)
|
Protein C concentrate
Protein C concentrate (human)
Protein C concentrate human
Protein C human
|
|
47 |
|
Lysine |
Approved, Nutraceutical |
|
|
56-87-1 |
5962 |
Synonyms:
(+)-S-Lysine
(S)-2,6-Diaminohexanoate
(S)-2,6-Diamino-hexanoate
(S)-2,6-Diaminohexanoic acid
(S)-2,6-Diamino-hexanoic acid
(S)-a,e-Diaminocaproate
(S)-a,e-Diaminocaproic acid
(S)-a,epsilon-Diaminocaproate
(S)-a,epsilon-Diaminocaproic acid
(S)-alpha,epsilon-Diaminocaproate
(S)-alpha,epsilon-Diaminocaproic acid
(S)-Lysine
(S)-Α,epsilon-diaminocaproate
(S)-Α,epsilon-diaminocaproic acid
(S)-α,ε-diaminocaproic acid
2,6-Diaminohexanoate
2,6-Diaminohexanoic acid
6-Amino-aminutrin
6-Amino-L-norleucine
6-Ammonio-L-norleucine
Acetate, lysine
alpha-Lysine
|
a-Lysine
Aminutrin
Enisyl
H-Lys-OH
K
L Lysine
L-(+)-Lysine
L-2,6-Diainohexanoate
L-2,6-Diainohexanoic acid
L-2,6-Diaminocaproate
L-2,6-Diaminocaproic acid
L-Lys
L-Lysin
L-Lysine
Lys
Lysina
Lysine
Lysine acetate
Lysine acid
Lysine hydrochloride
Lysinum
|
|
48 |
|
Menadione |
Approved, Nutraceutical |
|
|
58-27-5 |
4055 |
Synonyms:
2-METHYL-1,4-DIHYDRONAPHTHALENE-1,4-DIONE
2-Methyl-1,4-naftochinon
2-Methyl-1,4-naphthalendione
2-Methyl-1,4-naphthalenedione
2-Methyl-1,4-naphthochinon
2-Methyl-1,4-naphthodione
2-Methyl-1,4-naphthoquinone
2-Methylnaphthoquinone
3-Methyl-1,4-naphthoquinone
Aquakay
Aquinone
Bisulfite, menadione
Bisulfite, menadione sodium
Hemodal
Juva-K
Kaergona
Kanone
Kappaxan
Kappaxin
Karcon
Kareon
Kativ-g
Kayklot
Kaykot
Kaynone
Kayquinone
Kipca
Kipca-oil soluble
Klottone
Koaxin
Kolklot
|
K-Thrombyl
K-Vitan
Menadion
MENADIONE
Menadione bisulfite
Menadione sodium bisulfite
Menadione sodium bisulfite, trihydrate
Menaphthene
Menaphthon
Menaphthone
Menaphtone
Menaquinone
Menaquinone O
Mitenon
Mitenone
MNQ
NSC-4170
Panosine
Prokayvit
Sodium bisulfite, menadione
Synkay
Thyloquinone
Vicasol
Vikasol
Vitamin K 3
Vitamin K0
Vitamin K2
Vitamin K3
Vitamin K3 sodium bisulfite
Vitamin K3: 1,4-dihydro-1,4-dioxo-2-methylnaphthalene
|
|
49 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
|
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
50 |
|
Menaquinone |
Investigational |
|
|
1182-68-9 |
|
Interventional clinical trials:
(show top 50)
(show all 79)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Use of Warfarin After the First Trimester in Pregnant Women With Antiphospholipid Syndrome |
Unknown status |
NCT02303171 |
Phase 4 |
Enoxaparin;Warfarin |
2 |
Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases |
Unknown status |
NCT01151644 |
Phase 4 |
|
3 |
Rivaroxaban in Antiphospholipid Syndrome Pilot Study: A Multicenter Feasibility Study of Rivaroxaban for Patients With Antiphospholipid Syndrome and Prior Arterial or Venous Thrombosis |
Completed |
NCT02116036 |
Phase 4 |
Rivaroxaban |
4 |
Timing of Initiation of Low Molecular Weight Heparin Administration in Pregnant Women With Antiphospholipid Syndrome |
Completed |
NCT02326051 |
Phase 4 |
Enoxaparin |
5 |
Dose-dependent Drug-drug Interaction Between Paracetamol and Warfarin in Adults Receiving Long-term Oral Anticoagulants: A Randomized Controlled Trial |
Completed |
NCT01104337 |
Phase 4 |
paracetamol;Placebo |
6 |
Apixaban for the Secondary Prevention of Thromboembolism: a Prospective Randomized Outcome Pilot Study Among Patients With the AntiphosPholipid Syndrome |
Active, not recruiting |
NCT02295475 |
Phase 4 |
Apixaban;Warfarin |
7 |
A Multicenter, Double-blind, Randomized and Parallel Controlled Study of Hydroxychloroquine Sulfate in the Treatment of Recurrent Miscarriage With Antiphospholipid Syndrome |
Not yet recruiting |
NCT04624269 |
Phase 4 |
Hydroxychloroquine Sulfate Tablets |
8 |
Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome? |
Withdrawn |
NCT04274803 |
Phase 4 |
Intralipid, 20% Intravenous Emulsion;Conventional therapy of antiphospholipis syndrome |
9 |
Hydroxychloroquine Versus Placebo: Impact on Thrombotic Relapse in Primary Antiphospholipid Syndrome |
Unknown status |
NCT03540810 |
Phase 3 |
Hydroxychloroquine;Placebo |
10 |
Rivaroxaban Versus Acenocumarol for Secondary Thromboprophylaxis in Patients With Antiphospholipid Syndrome: a Randomized, Prospective, Phase III Study. Analysis of Stratification Prognostic Factors |
Completed |
NCT02926170 |
Phase 3 |
Rivaroxaban;acenocumarol |
11 |
Rivaroxaban Versus Warfarin for Stroke Patients With Antiphospholipid Syndrome, With or Without SLE (RISAPS): a Randomised, Controlled, Open Label, Phase II/III, Non-inferiority Trial |
Recruiting |
NCT03684564 |
Phase 2, Phase 3 |
Rivaroxaban;Warfarin |
12 |
Open-label, Prospective, Phase II Descriptive Pilot Trial of Belimumab Therapy for Refractory and/or Non-criteria Manifestations of Antiphospholipid Syndrome |
Recruiting |
NCT05020782 |
Phase 2, Phase 3 |
Belimumab |
13 |
A Prospective, Randomized Clinical Trial Comparing Rivaroxaban vs Warfarin in High Risk Patients With Antiphospholipid Syndrome |
Terminated |
NCT02157272 |
Phase 3 |
Experimental: Rivaroxaban |
14 |
A Prospective Randomized Controlled Trial of Hydroxychloroquine in the Primary Thrombosis Prophylaxis of aPL Positive But Thrombosis-free Patients. |
Terminated |
NCT01784523 |
Phase 3 |
Hydroxychloroquine |
15 |
Efficiency of Hydroxychloroquine on the Endothelial Dysfunction in Antiphospholipid Syndrome (APLAQUINE) |
Unknown status |
NCT02595346 |
Phase 2 |
Hydroxychloroquine;placebo |
16 |
Randomised Controlled Trial of Low Dose Steroid +Aspirin +Heparin Versus Aspirin+Heparin Amongst Pregnant Women With APS |
Unknown status |
NCT00180778 |
Phase 1, Phase 2 |
Low dose steroids |
17 |
A Pilot Study of Rituximab for the Anticoagulation Resistant Manifestations of Antiphospholipid Syndrome (RITAPS) |
Completed |
NCT00537290 |
Phase 2 |
Rituximab |
18 |
Effects of Fluvastatin on Proinflammatory and Prothrombotic Markers in Antiphospholipid Syndrome Patients |
Completed |
NCT00674297 |
Phase 2 |
Fluvastatin |
19 |
Low-molecular-weight Heparin Versus Unfractionated Heparin in Pregnant Women With History of Recurrent Abortion Secondary to Antiphospholipid Syndrome. A Randomized Controlled Trial |
Completed |
NCT01051778 |
Phase 2 |
enoxaparin 40mg plus low dose aspirin;Heparin calcium5,000 U twice daily plus low dose aspirin |
20 |
Eculizumab to Enable Renal Transplantation in Patients With History of Antiphospholipid Antibody Syndrome or Catastrophic Antiphospholipid Antibody Syndrome |
Completed |
NCT01029587 |
Phase 2 |
Eculizumab |
21 |
Evaluation of the Benefit of Adjuvant Treatment With Hydroxychloroquine to the Usual Medical Management for Obtaining an Uncomplicated Term Pregnancy in Primary Obstetric Antiphospholipid Syndrome |
Recruiting |
NCT04275778 |
Phase 2 |
Plaquenil 200Mg Tablet;Placebo oral tablet |
22 |
Prospective, Single Arm and Open Clinical Observation of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia |
Recruiting |
NCT05199909 |
Phase 2 |
zanubrutinib |
23 |
Certolizumab to Prevent Pregnancy Complications in High-Risk Patients With APS or SLE - (IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy) |
Recruiting |
NCT03152058 |
Phase 2 |
Certolizumab Pegol |
24 |
A Pilot Study of Telitacicept Treatment in Primary APS Patients |
Recruiting |
NCT05078710 |
Phase 2 |
Telitacicept |
25 |
An Open-Label Proof of Concept Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome |
Terminated |
NCT02128269 |
Phase 2 |
|
26 |
High Dose Cyclophosphamide & CAMPATH-1H With Hematopoietic Stem Cell Transplantation in Patients With Refractory Antiphospholipid Syndrome (APS): A Phase I Trial |
Withdrawn |
NCT00278616 |
Phase 1 |
|
27 |
Efficacy of EPA and DHA Supplementation in Systemic Lupus Erythematosus and Primary Antiphospholipid Syndrome |
Unknown status |
NCT01956188 |
|
|
28 |
A Randomized Clinical Trial of Using Preconceptional Enoxaparin AND Low Dose Aspirin 81mg in Patient With Antiphospholipid Syndrome(APS) |
Unknown status |
NCT01661439 |
|
low molecular weight heparin (enoxeparine) |
29 |
TheValue of Placental Vascularization Indices and Placental Volume in Pregnancies With Antiphospholipid Syndrome for Prediction of Neonatal Outcome" |
Unknown status |
NCT03505840 |
|
|
30 |
Detection Of Anti-Double Stranded Deoxyribonucleic Acid Antibodies In Autoimmune Rheumatic Diseases: Comparison Between Immunofluorescence And Enzyme Immunoassay |
Unknown status |
NCT03303508 |
|
|
31 |
Monitoring the Antiphospholipid Syndrome:TOXicity of Drugs (APSTOX) |
Unknown status |
NCT03994302 |
|
Drug inducing antiphospholipid syndrome |
32 |
Prevalence of Lysosomal Hydrolase Alpha-glagtosidase Deficiency in Patients |
Unknown status |
NCT03384485 |
|
|
33 |
The Influence of Antiphospholipid Antibodies on the Relationship Between Hyperurecemia, Gout and Metabolic Syndrome |
Unknown status |
NCT01818505 |
|
|
34 |
Antiphospholipid Antibodies and Early Fetal Growth Restriction (<34 Weeks of Gestation). A Case Control Study. |
Unknown status |
NCT01538134 |
|
|
35 |
Antiphospholipid Antibodies and Early Severe Preeclampsia (< 34 Weeks of Gestation). A Case-Control Study. |
Unknown status |
NCT01538121 |
|
|
36 |
Assessement of a Multi-organ Screening Procedure for the Detection of Pre-clinical Ischaemia in Antiphospholipid Syndrome The COBRA Study (CardiO-Brain Renal Involvement in Antiphospholipid Syndrome) |
Completed |
NCT03348306 |
|
|
37 |
Effect of Hydroxychloroquine on Thrombosis Prevention and Antiphospholipid Antibody Levels in Patients With Primary Antiphospholipid Syndrome: An Pilot Randomized Prospective Study. |
Completed |
NCT04153201 |
|
Hydroxychloroquine |
38 |
Medium-term Follow-up of Patients With Obstetric Antiphospholipid Syndrome: MRI Study of White Matter |
Completed |
NCT03600636 |
|
|
39 |
Monitoring Anticoagulant Therapy With Vitamin-K Antagonists in Patients With Antiphospholipid Syndrome |
Completed |
NCT01660061 |
|
|
40 |
Antiphospholipid Syndrome Collaborative Registry (APSCORE) |
Completed |
NCT00076713 |
|
|
41 |
Hypercoagulable Phenotype by Thrombinography (in Presence of C Protein Dynamic Inhibitory System): Marker of Venous Thrombosis Risk in Systemic Lupus and Antiphospholipid Syndrome? Case-control Study |
Completed |
NCT02892565 |
|
|
42 |
Ocular Findings in Women With Primary Antiphospholipid Syndrome and Their Association to Bad Obstetric Outcome |
Completed |
NCT03459508 |
|
|
43 |
Clinical Features and Pattern of Antiphospholipid Antibodies in Patients of Antiphospholipid Syndrome (APS) With Systemic Lupus Erythematosus (SLE). |
Completed |
NCT04963881 |
|
|
44 |
Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome |
Completed |
NCT02833194 |
|
|
45 |
Evaluation of the Precision and Accuracy of International Normalised Ratio (INR) Measurements as Assessed by the LumiraDx Instrument in a Professional Point of Care Setting With Multiple Operators |
Completed |
NCT03682419 |
|
|
46 |
Retrospective Study of the Prevalence of Antiphospholipid Antibodies in the Population of Hemodialysis Patients at the CHU Brugmann Hospital |
Completed |
NCT03893357 |
|
|
47 |
Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies in Women Presenting as Recurrent Miscarriages. |
Completed |
NCT00180817 |
|
|
48 |
INR Determined by Plasma-based Methods Versus Newer Point-of-care Instruments in Patients With Antiphospholipid-antibody Syndrome Treated With Anticoagulants |
Completed |
NCT00878137 |
|
|
49 |
Evaluation of the Incidence of Cancer in the Follow-up of Women With 3 Consecutive Embryonic Demises Before 10 Weeks or 1 Fetal Death, According to Their Thrombophilia Status, With a Special Focus on Women With an Obstetric Antiphospholipid Symdrome (oAPS) |
Completed |
NCT03969498 |
|
|
50 |
Effect of Hydroxychloroquine on the Annexin A5 Resistance Assay in Antiphospholipid Antibody-Positive Patients With and Without Systemic Lupus Erythematosus |
Completed |
NCT01475149 |
|
|
|